Here are relevant reports on : digital-pharma-market
-
Analytical Standards Market by Technique (GC, LC, TLC, IR, MS, NMR, Titrimetry), Category (Organic, Inorganic), Method (Bioanalytical, Dissolution), Application (F&B, Environmental, Pharma, Clinical Diagnostic, Forensics), Region - Global Forecast to 2030
The global analytical standards market, valued at US$1.44 billion in 2022, stood at US$1.53 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$2.16 billion by the end of the period. The key factors driving the market growth include the stringent regulatory guidelines in the pharmaceutical industry; increasing public-private investments for research projects; the rising public concerns about food safety & quality; and the growing applications of analytical techniques in proteomics and metabolomics.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030
The global European infection control market, valued at US$14.14 billion in 2024, stood at US$14.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$20.58 billion by the end of the period. The growth of the European infection control market in Germany is strongly supported by the high infectious disease burden, increasing awareness on early disease diagnosis, and expanding public health initiatives and infection control programs.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030
The global lab automation market, valued at US$5.97 billion in 2024, stood at US$6.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.2% from 2025 to 2030, culminating in a forecasted valuation of US$9.01 billion by the end of the period. The primary driver of this growth is the increasing demand for high-throughput screening, which enables laboratories to efficiently process large volumes of samples in drug discovery and diagnostics.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Chromatography Accessories & Consumables Market by Technology (GC, HPLC, UPLC, LPLC, Flash), Product (Columns (Prepacked, Empty), Detectors, Autosamplers, Vials, Septa, Degassers), End User (Pharma-Biopharma, Academia, F&B, O&G) - Global Forecasts to 2030
Global chromatography accessories & consumables market valued at $4.79B in 2023, reached $6.10B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $8.74B by 2030. The key factors contributing to market growth include the growing popularity of hyphenated chromatography techniques, the rising use of chromatography for food safety applications, the growing importance of chromatography tests in drug development, and the increasing demand for environmental analysis.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Temperature Controlled Packaging Solutions Market by Type (Active, Passive), Product, Usability (Single, Reuse), Revenue type (Product, Service), End-Use Industry (Pharma and Biopharma) & Region - Trends and Forecasts (2022 - 2026)
The Temperature Controlled Packaging Solutions Market is expected to grow from USD 34.4 billion in 2021 to USD 80.1 billion by 2026, at a CAGR of 18.4% during the forecast period. The leading players in the TCP market are Sonoco Products Company (US), Cold Chain Technologies, LLC (US), Va-Q-Tec AG (Germany), Pelican BioThermal LLC (US), Softbox Systems (UK), Sofrigam SA (France), DGP Intelsius GMBH (UK), Inmark, LLC (US), Envirotainer AB (Sweden), Fedex Corporation (US) and Amerisourcebergen Corporation (US).
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Infection Control Market by Product (Sterilization Equipment: Hydrogen Peroxide, Ethylene, Radiation), Service (ETO, Gamma, E-Beam), Disinfection (Wipes, Disinfector), Gown, Mask, Endoscope Reprocessing, End User (Hospital, Pharma) - Global Forecast to 2030
The infection control market is expected to grow from USD 57.31 billion in 2025 to USD 77.67 billion by 2030, at a CAGR of 6.3% during the forecast period. Prominent players in the infection control market include STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), Solventum (US), Getinge AB (Sweden), Ecolab, Inc. (US), Olympus Corporation (Japan), Envista (US), and PAUL HARTMANN AG (Germany).
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Asset Management Market by Product (RFID (Active, Passive), RTLS, Ultrasound, Infrared), Application (Hospital (Equipment, Patient Monitoring, Staff Management, Hand Hygiene), Pharma (Drug Counterfeiting, Supply Chain)) - Global Forecast to 2023
The global healthcare asset management market is projected to reach USD 35.19 billion by 2023, at a CAGR of 31.4%. The growth of the healthcare asset management market is driven by need for better asset management in hospitals, acceptance of asset management solutions in the pharmaceutical industry, and decline in prices of RFID Tags. While the healthcare asset management market represents significant growth opportunities, market growth may be hindered due to the high cost of RFID readers. The healthcare asset management market is marked by the presence of several big and small players. Prominent players offering healthcre asset mangement market include AiRISTA Flow (US), Elpas (US), CenTrak, Inc.(US), ThingMagic [A Novanta Company (US], Sonitor (Norway), Stanley Healthcare (US), Versus Technology, Inc. (US), Zebra Technologies (US), GE Healthcare (US), and IBM Corporation (US).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Interactive Voice Response Market by Technology (Touch-Tone and Speech), Deployment (Cloud and on Premise), Vertical (BFSI, Pharma and Healthcare, ITES), Organization Size, Solution, Service, And Geography - Global Forecast to 2023
The overall interactive voice response market is projected to exhibit a lucrative growth potential between 2017 and 2023. The interactive voice response (IVR) market was valued at USD 3.73 Billion in 2017 and is expected to reach USD 5.54 Billion by 2023, at a CAGR of 6.83% during the forecast period. The growth of the IVR market is attributed to the increasing integration of advanced technologies and rise in the cloud-based services that meet the industry standards for the IVR systems. The key market players in the North America are inContact Inc. (US), Nuance Communications, Inc. (US), Convergys Corporation (US), Avaya Inc. (US), Cisco Systems, Inc. (US), AT&T Inc. (US), West Corporation (US), Genesys Telecommunication Laboratories, Inc. (US), Verizon Communications Inc. (US), and 24/7 Customer, Inc. (US).
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
